Schrödinger, Sanofi sign $120m drug discovery deal – Pharmaceutical Business Review

US-based computational drug designer Schrödinger has entered into a multi-year early drug discovery collaboration with Sanofi in which Schrödinger wil

Source: drugdiscovery.pharmaceutical-business-review.com

---